Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,233.00
+14.20 (1.17%)
Oct 16, 2026, 3:29 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.03 trillion as of October 16, 2026. Its market cap has increased by 0.02% in one year.
Market Cap
1.03T
Enterprise Value
1.02T
Revenue
331.19B
Global Rank
n/a
Country Rank
n/a
PE Ratio
30.99
ChartMarket Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.03T, an increase of 4,785.23%. That is a compound annual growth rate of 15.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.03T | -3.03% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.43T |
| Zydus Lifesciences | 1.12T |
| Laurus Labs | 1.11T |
| Cipla | 1.07T |
| Aurobindo Pharma | 959.10B |
| Mankind Pharma | 939.77B |
| Glenmark Pharmaceuticals | 628.38B |
| Alkem Laboratories | 603.80B |